By Vvon Engineering Team | Published | Updated
Build a hospital-specific investment model from referral evidence, net receipts, supply, staffing, capital, service risk and timed cash flows.
Nuclear medicine RFQ checklist (TXT)
A nuclear-medicine investment case depends on clinically justified demand, equipment and site scope, staffing, supply, prices, service continuity and financing. Similar cameras can produce different financial outcomes, but equipment capability and reliability also influence the result. Treat payback as a model output with explicit assumptions.
Use current, verifiable catchment evidence: referral destinations, waiting times, clinically appropriate study volumes, travel burden and confirmed capacity at nearby centres. Do not use an unverified national camera count or a claimed one-camera-per-500,000 benchmark to prove demand.
Unmet clinical need does not automatically become affordable, collectable demand for a particular hospital. Validate referral access, patient affordability, staffing and supply before describing the investment as favourable.
Build revenue by study using the hospital's expected net receipts after discounts, contractual payments and uncollected amounts. Bone, cardiac, thyroid and renal volumes vary by catchment; no unsourced national fee range or default highest-volume procedure should stand in for local evidence.
| Model input | Evidence to collect | How to use it |
|---|---|---|
| Studies by type | Referrals, existing outsourced studies and clinically appropriate forecast | Low, base and high monthly volume with ramp-up |
| Net receipt per study | Approved tariff, payer terms, discounts and collection history | Use expected collected revenue, not advertised price alone |
| Variable cost | Quoted tracers/kits, consumables and study-specific costs | Calculate contribution by study without double counting |
| Fixed and step costs | Staffing cover, facilities, QA, service and administration | Separate fixed costs from costs that rise with capacity |
| Capital and replacement | Dated landed equipment and building quotes, major-part scenarios | Time cash outflows and include contingencies |
| Finance and working capital | Funding terms, taxes, payment delays and inventory commitments | Assess cash flow as well as accounting surplus |
Test ramp-up with the hospital's actual referral plan. Neither 165 studies within 12–18 months nor 250 within three years is a verified benchmark or promised outcome.
Estimate each study category independently. An established oncology or cardiology service may support referrals, but case mix, clinical appropriateness, affordability and alternatives determine the likely volume and contribution.
This matters at specification stage, not afterwards. A department that expects to be cardiac-heavy is buying different acquisition capability, different collimators and a different room layout from one that expects to be oncology-heavy. Work out your likely case mix from the referral book you already have, procedure by procedure, before the equipment specification is written. The most expensive mistake in this vertical is not overpaying for a camera. It is buying a camera configured for the department you imagined rather than the one your referrals will produce.
Nuclear medicine has almost no self-referral. Every study on the list arrives because a physician somewhere decided to order it, which means volume is a function of how many ordering physicians know the service exists, trust the report, and get the result back in time to act on it.
Review internal referrals and external referral arrangements separately, using actual records and achievable reporting support. Map competing and complementary centres, patient travel and current service gaps without assuming capacity is almost entirely in two cities. Measure the effect of reporting and communication on service use instead of assigning an unsupported national growth pattern.
Supply and product timing constrain scheduling. Generator yield, elution history, activity reference dates, preparation and expiry must be assessed with the authorised provider. Daily averages can be useful summaries, but the operational model should also test actual delivery and use patterns.
Model disruptions using the actual generator, unit-dose or other product arrangement and available alternatives. A delayed delivery can reduce capacity without necessarily losing an entire week. Confirm import, transport, product and holiday constraints before starting the service.
Compare realistic supply-day schedules and sensitivity to disruption alongside price and volume assumptions. Do not assume this single variable always dominates the financial case.
Use a workload-based staffing plan covering clinical reporting, operation, radiopharmacy, medical physics, radiation protection, nursing and engineering or IT support as needed. One physician, two technologists and one radiopharmacist is not a complete universal staffing standard.
Ask the questions before commissioning rather than after. Who reports when the physician is on leave? Who elutes and dispenses when the radiopharmacist is ill? Is there a second technologist trained on the same acquisition protocols, or does the department run on one person's familiarity with the console? A hospital that has not answered those is not buying a department, it is buying a camera with a rota problem attached, and its utilisation will show it.
Obtain dated local quotations for radiopharmaceuticals, staffing cover, QA, utilities, service, facilities and administration. Include regulatory obligations, waste arrangements and contingencies where applicable. Without those inputs, a BDT 600,000–900,000 monthly cost or BDT 1.1–1.5 million surplus would be an unsupported estimate.
Evaluate whether any validated activity reduction changes the actual supply cost; fixed generator or kit commitments may limit savings. Compare maintenance scope and outage scenarios rather than assuming every uncovered fault costs exactly one month of revenue.
Define project capital from dated equipment, import, building, shielding, radiopharmacy, IT, QA, training and commissioning quotations. A simple payback calculation divides initial investment by stable annual net cash inflow, but should be supplemented by a timed cash-flow model when ramp-up, financing, replacement and working capital matter. If cash inflow is negative or inadequate, payback may never occur; no universal BDT capital band or five-to-ten-year result is justified here.
Compare low, base and high scenarios for referrals, collection, supply cost, staffing, downtime, foreign exchange and major repairs. State who owns each assumption and when it was checked. Assess cash affordability and clinical value as well as payback; neither daily hours nor attendance promises alone fixes the outcome.
BAERA is the relevant radiation regulator; confirm the current design, import, possession, use and other authorisation requirements for the proposed practice. Establish dependencies with the competent teams and budget the required work. BAEC can have service or supply roles but is not a substitute licensing body. Any supplier documentation assistance must be specified separately and cannot guarantee approval.
Send Vvon the expected studies, existing referrals, room plan and equipment scope for a quotation that can feed your institution's business case. Your finance and clinical teams should validate demand and cash-flow assumptions against dated evidence. Contact +8801805987890 or info@vvon.com.bd.
Share your application, equipment requirements and procurement timeline. Our engineers can help clarify the configuration and scope for your enquiry.